Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPROVE Intervention Trial
2018-000070-30Phase 2Terminated
- Sponsor
- Aarhus University Hospital
- Start
- Jan 2018
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of oxaliplatin in colorectal cancer (CRC), sponsored by Aarhus University Hospital. Primary endpoint: Disease-free survival at 3 years. Started Jan 2018; status: terminated.
02
Drugs
oxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2018-000070-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000070-30.